Literature DB >> 33234023

The Hippo Pathway in Liver Homeostasis and Pathophysiology.

Jordan H Driskill1,2, Duojia Pan1.   

Abstract

Studies of the regenerative capacity of the liver have converged on the Hippo pathway, a serine/threonine kinase cascade discovered in Drosophila and conserved from unicellular organisms to mammals. Genetic studies of mouse and rat livers have revealed that the Hippo pathway is a key regulator of liver size, regeneration, development, metabolism, and homeostasis and that perturbations in the Hippo pathway can lead to the development of common liver diseases, such as fatty liver disease and liver cancer. In turn, pharmacological targeting of the Hippo pathway may be utilized to boost regeneration and to prevent the development and progression of liver diseases. We review current insights provided by the Hippo pathway into liver pathophysiology. Furthermore, we present a path forward for future studies to understand how newly identified components of the Hippo pathway may control liver physiology and how the Hippo pathway is regulated in the liver.

Entities:  

Keywords:  Hippo pathway; YAP/TAZ; fatty liver disease; liver cancer; metabolism; regeneration

Mesh:

Substances:

Year:  2020        PMID: 33234023     DOI: 10.1146/annurev-pathol-030420-105050

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  17 in total

1.  Hepatocyte-Specific Deletion of Yes-Associated Protein Improves Recovery From Acetaminophen-Induced Acute Liver Injury.

Authors:  Samikshya Poudel; Diego Paine Cabrera; Bharat Bhushan; Michael W Manley; Sumedha Gunewardena; Hartmut Jaeschke; Udayan Apte
Journal:  Toxicol Sci       Date:  2021-11-24       Impact factor: 4.109

Review 2.  Mechanical regulation of chromatin and transcription.

Authors:  Sirio Dupont; Sara A Wickström
Journal:  Nat Rev Genet       Date:  2022-05-23       Impact factor: 59.581

3.  The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease.

Authors:  Antonio Cigliano; Shanshan Zhang; Silvia Ribback; Sara Steinmann; Marcella Sini; Cindy E Ament; Kirsten Utpatel; Xinhua Song; Jingxiao Wang; Maria G Pilo; Fabian Berger; Haichuan Wang; Junyan Tao; Xiaolei Li; Giovanni M Pes; Serena Mancarella; Gianluigi Giannelli; Frank Dombrowski; Matthias Evert; Diego F Calvisi; Xin Chen; Katja Evert
Journal:  J Exp Clin Cancer Res       Date:  2022-06-03

Review 4.  Role of YAP1 Signaling in Biliary Development, Repair, and Disease.

Authors:  Laura Molina; Kari Nejak-Bowen; Satdarshan P Monga
Journal:  Semin Liver Dis       Date:  2022-01-24       Impact factor: 6.512

5.  TAZ as a novel regulator of oxidative damage in decidualization via Nrf2/ARE/Foxo1 pathway.

Authors:  Hai-Fan Yu; Lian-Wen Zheng; Zhan-Qing Yang; Yu-Si Wang; Ting-Ting Wang; Zhan-Peng Yue; Bin Guo
Journal:  Exp Mol Med       Date:  2021-09-08       Impact factor: 12.153

6.  Signal Transduction and Molecular Regulation in Fatty Liver Disease.

Authors:  Xiaocheng Charlie Dong; Kushan Chowdhury; Menghao Huang; Hyeong Geug Kim
Journal:  Antioxid Redox Signal       Date:  2021-06-03       Impact factor: 7.468

Review 7.  Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.

Authors:  Hiroshi Nishina
Journal:  Cancer Sci       Date:  2022-04-17       Impact factor: 6.518

8.  Ionizing radiation-induced long noncoding RNA CRYBG3 regulates YAP/TAZ through mechanotransduction.

Authors:  Lijun Zheng; Chenyu Luo; Nan Yang; Hailong Pei; Mintao Ji; Yinyin Shu; Zhisen Zhang; Shuai Dong; Xiuxiu Wang; Xuemei Li; Wensheng Zhang; Yan Wang; Bingyan Li; Tom K Hei; Guangming Zhou; Lei Chang
Journal:  Cell Death Dis       Date:  2022-03-04       Impact factor: 8.469

Review 9.  MicroRNAs Regulating Hippo-YAP Signaling in Liver Cancer.

Authors:  Na-Hyun Lee; So Jung Kim; Jeongeun Hyun
Journal:  Biomedicines       Date:  2021-03-30

10.  Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.

Authors:  Hongyan Wang; Xin Di; Yingjie Bi; Shidong Sun; Tao Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.